Learning-Based Classification of B- and T-Cell Lymphoma on Histopathological Images: A Multicenter Study.

Journal: European journal of haematology
Published Date:

Abstract

Lymphoma, a clonal malignancy from lymphocytes, includes diverse subtypes requiring distinct immunohistochemical stains for accurate diagnosis. Limited biopsy specimens often restrict the use of multiple stains, complicating diagnostic workflows. Lymphomas are typically classified into B-cell and T-cell types, each with specific markers. This study represents the first feasibility study in deploying deep learning models for B- and T-cell lymphoma classification on histopathological images. We analyzed 1510 H&E-stained sections (750 B-cell, 760 T-cell) with CNN models (Xception, NASNetL, ResNet50, EfficientNet), enhanced by Convolutional Block Attention Modules (CBAMs). All models demonstrated strong classification capabilities, with EfficientNet achieving the highest accuracy at 91.5% and the best precision at 91.9%, while Xception performed the best recall at 91.5%. Furthermore, the deep learning models significantly outperformed human pathologists in classification accuracy and inference speed, processing images in milliseconds compared to the several seconds required for manual diagnosis. These findings underscore the effectiveness of advanced CNN models in improving diagnostic precision while reducing dependency on manual staining and interpretation, and the integration of AI-driven classification can provide valuable support for pathologists.

Authors

  • Yuhua Ru
    National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xing Tong
    Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Jiaxi Lin
    Department of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
  • Fang Chen
  • Zhe Wang
    Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China.
  • Xiangdong Shen
    Affiliated Hospital of Nantong University, Nantong, China.
  • Jie Zhao
    Department of Liver & Gallbladder Surgery, The First People's Hospital, Shangqiu, Henan, China.
  • Yutong Jing
    The Soochow Hopes Hematonosis Hospital, Suzhou, China.
  • Yiyang Ding
    Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Jinjin Zhu
    National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Mimi Xu
    National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Jinzhou Zhu
    Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
  • Jia Chen
    Department of Oncology Internal Medicine, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
  • Depei Wu
    National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.